Viewing Study NCT00290303


Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2026-02-01 @ 4:26 AM
Study NCT ID: NCT00290303
Status: COMPLETED
Last Update Posted: 2016-09-16
First Post: 2006-02-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Haemophilus Influenzae Type b View
None Diphtheria View
None Whole Cell Pertussis View
None Hepatitis B View
None Tetanus View
Keywords: